Prosecution Insights
Last updated: October 26, 2026

Daniel John Burkett, USPTO Patent Examiner

Listed by the USPTO as BURKETT, DANIEL JOHN

Tech Center 3600 • Art Units: 1600 1621 1624 1625 1626 3646

This examiner grants 63% of resolved cases

Analysis

BURKETT, DANIEL JOHN works in technology center 3600 and art unit 1600. The profile covers 101 resolved cases, an allowance rate of 63.4%, an interview lift of 33.2%, and a median of 1220 days to allowance. The smaller record limits broad inference, but the figures support combining written prosecution with targeted examiner discussions when claim scope or technical distinctions require clarification.

The listed companies are LG Chem Ltd., Institut National de La Sante Et de La Recherche Medicale, and Provibio Co. Ltd. The listed firms are Conley Rose, P.C., VIKSNINS HARRIS PADYS MALEN LLP, and BELL & ASSOCIATES. Counsel should account for the reported pendency and preserve technically supported fallback positions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

63.4%
Allow Rate
+11.4% vs TC avg
154
Total Applications
+33.2%
Interview Lift
1220
Avg Prosecution Days
Based on 101 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
20.7%
§102 Novelty
18.5%
§103 Obviousness
43.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18691241 MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE Final Rejection Boehringer Ingelheim International GMBH
18855254 COMBINATION METABOLIC-EPIGENETIC TREATMENT FOR EARLY LUNG CANCER Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18586471 METHODS AND COMPOSITIONS FOR TREATING THROMBOTIC DISEASE Final Rejection WASHINGTON UNIVERSITY
18176877 INHIBITION OF URACIL DNA GLYCOSYLASE IN THE OPEN CONFORMATION Non-Final OA CASE WESTERN RESERVE UNIVERSITY
18251101 CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR Non-Final OA LG CHEM, LTD.
18017732 METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED REACTION COMPOSITION Final Rejection LG CHEM, LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Daniel John Burkett's allowance rate?

63.4% of resolved applications examined by Daniel John Burkett were allowed (101 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.

Does an interview help with examiner Daniel John Burkett?

This examiner's interview lift is +33.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Daniel John Burkett take to allow a patent?

Applications allowed by Daniel John Burkett took 1,220 days on average from filing to allowance.

Which art unit does examiner Daniel John Burkett work in?

Daniel John Burkett examines applications in Art Unit 1600 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month